Mesoblast Ltd

NASDAQ: MESO
$17.53
-$0.76 (-4.2%)
Closing Price on December 27, 2024

MESO Stock Chart and Intraday Price

MESO Stock Data

Asset Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, AU
Fiscal Year End June
Latest Quarter 2023-06-30
Market Cap 596.70M USD
Shares Outstanding 101,480,000
Mesoblast Limited, a biopharmaceutical company, develops and markets allogeneic cellular drugs. The company is headquartered in Melbourne, Australia.

MESO Articles

Mesoblast shares more than doubled on Friday after the company provided an update on its COVID-19 treatment. Should it be taken with a grain of salt?
More and more companies are joining the fight against the coronavirus, and 24/7 Wall St. is taking a look at some of the biggest movers on the day tied to COVID-19.